Figure 1: Fludarabine leads to a loss of STAT1 activation after cytokine treatment of PBMC. Figure 2: Fludarabine leads to a selective loss of STAT1 protein and mRNA from lymphoid cells.

Phase 1 Dose Expansion Initiated for FT819 Off-the-Shelf CAR T-cell Product Candidate with Fludarabine-free Conditioning in Moderate-to-Severe ...

A new research paper titled "ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells" has been published in Oncotarget. ABT199 ...